BeOne Medicines AG ( ONC) - Stock Earnings
ONC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 66.5 million USD | 1.5 billion USD |
| 2026Q1 | 227.4 million USD | 1.5 billion USD |
| 2026Q2 | 237.0 million USD | 1.7 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ONC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -881.7 million USD | 2.5 billion USD |
| 2024 | -644.8 million USD | 3.8 billion USD |
| 2025 | 286.9 million USD | 5.3 billion USD |
| 2026 Est. | — | — |
ONC
Price: $376.86
52 week price:
Earnings Per Share: 5.60 USD
P/E Ratio: 64.16
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 40.6 billion